Follow
Bojan Ristivojevic
Bojan Ristivojevic
Junior Researcher, Institute of Molecular Genetics and Genetic Engineering
Verified email at imgge.bg.ac.rs
Title
Cited by
Cited by
Year
Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment
N Kotur, J Lazic, B Ristivojevic, B Stankovic, V Gasic, L Dokmanovic, ...
Genes 11 (4), 468, 2020
262020
Genome-wide association study of COVID-19 outcomes reveals novel host genetic risk loci in the Serbian population
M Zecevic, N Kotur, B Ristivojevic, V Gasic, V Skodric-Trifunovic, ...
Frontiers in Genetics, 1793, 0
13
Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
B Stanković, N Kotur, V Gašić, K Klaassen, B Ristivojević, M Stojiljković, ...
Journal of medical biochemistry 39 (4), 488, 2020
122020
Analysis of the promoter regions of disease-causing genes in maturity-onset diabetes of the young patients
J Komazec, B Ristivojevic, B Zukic, V Zdravkovic, T Karan-Djurasevic, ...
Molecular Biology Reports 47 (9), 6759-6768, 2020
32020
Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?
M Jelovac, N Kotur, B Ristivojevic, D Pavlovic, V Spasovski, N Damjanov, ...
International Journal of Molecular Sciences 24 (10), 8538, 2023
12023
Farmakogenetički markeri odgovora na terapiju tiopurinskim lekovima, metotreksatom i vinkristinom kod dece sa akutnom limfoblastnom leukemijom
BM Ristivojević
Univerzitet u Beogradu-Biološki fakultet, 2023
2023
The pharmacogenomics of vincristine-induced peripheral neuropathy in pediatric acute lymphoblastic leukemia patients in Serbia-a single center experience
B Ristivojević, N Kotur, B Stanković, V Gašić, J Lazić, S Pavlović, B Zukić
Srpski arhiv za celokupno lekarstvo, 99-99, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–7